PET scans were acquired using either
Signa PET/MRI 3 Tesla system (GE Healthcare, Waukesha, WI, USA; N = 39) or PET/CT systems (
Discovery-STE or
Discovery-690, GE Healthcare, Waukesha, WI, USA; N = 41). [
68Ga]Ga-PSMA-11 PET/MRI scans were acquired according to a previously published protocol [16 (
link)]. PET/CT scans were acquired according to the joint EANM and SNMMI procedure guidelines for PCa imaging [17 (
link)]. [
68Ga]Ga-PSMA-11 PET image read-out was performed by two Nuclear Medicine Physicians with knowledge of all the available patients’ clinical and imaging information on the
Advantage Workstation (AW, General Electric Healthcare, Waukesha, WI, USA), on which PET, MRI, CT, and fused images could be visualized in axial, coronal, and sagittal planes. In the event of disagreement or uncertain findings, the images were re-examined, and a consensus was reached. The whole-body distribution pattern of [
68Ga]Ga-PSMA-11 was qualitatively assessed, and the presence of increased uptake deviating from the physiological distribution of the tracer was considered positive for malignancy [18 (
link)]. The anatomical sites were defined based on MR or CT images co-registered with PET examinations.
Mapelli P., Ghezzo S., Pini C., Samanes Gajate A.M., Spataro A., Bezzi C., Landoni C., Scifo P., Briganti A., Chiti A, & Picchio M. (2023). Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy. Cancers, 15(18), 4589.